Overview

We are a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Click on the link below for our latest corporate presentation.

Clinical Trials Information

Resources and guides for patients and caregivers.

Click on the link below for more information.

Latest News

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
Read More

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close